Online Database of Chemicals from Around the World 产品搜索 | 产品提交 | 产品推广

网站主页 >> 化工产品目录 >> 半胱天冬酶-3 抑制剂 III>> 市场分析报告
 




半胱天冬酶-3 抑制剂 III市场分析报告

Caspases Inhibitor -Pipeline Insight, 2019
This report can be delivered to the clients within 48 hrs “Caspases Inhibitor - Pipeline Insight, 2019” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across “Caspases ...

Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H2 2018
Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H2 2018 SUMMARY According to the recently published report 'Caspase 3 - Pipeline Review, H2 2018'; Caspase 3 (Apopain ...

Caspase 8 (Apoptotic Cysteine Protease or Apoptotic Protease Mch 5 or CAP4 or FADD Homologous ICE/Ced-3 Like Protease or FADD Like ICE or ICE Like Apoptotic Protease 5 or MORT1 Associated Ced 3 Homolog or CASP8 or EC 3.4.22.61) - Pipeline Review, H2 2018
Caspase 8 (Apoptotic Cysteine Protease or Apoptotic Protease Mch 5 or CAP4 or FADD Homologous ICE/Ced-3 Like Protease or FADD Like ICE or ICE Like Apoptotic Protease 5 or MORT1 Associated Ced 3 Homolog or CASP8 or EC 3.4.22.61) - Pipeline Review, H2 2018 ...

Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) - Pipeline Review, H2 2018
Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE Like Apoptotic Protease 6 or CASP9 or EC 3.4.22.62) - Pipeline Review, H2 2018 SUMMARY Caspase 9 (Apoptotic Protease Mch 6 or Apoptotic Protease Activating Factor 3 or ICE ...

Non-Alcoholic SteatoHepatitis (NASH): An Analysis of Disease Prevalence, Drugs in development, Regulatory guidelines and Market opportunity in Various Geographies
Sales of Hepatitis C drugs crossed ~$10bn in 2014 proving that treatments for liver disease could become mega-blockbusters and Non-Alcoholic SteatoHepatitis (NASH) is expected to be equally lucrative. Improved diagnosis rate and change in treatment ...

Caspases Inhibitor -Pipeline Intelligence, 2019
... within 1-2 Business Days. CmaxInsight’s, “Caspases Inhibitor-Pipeline Intelligence, 2019”, report ... NDA/BLA Filing, Phase III, Phase II, Phase I, Pre-Clinical ... and opportunities that influence Caspases Inhibitor R&D Please note: Certain sections in ...

Bcl 2 Like Protein 1 - Pipeline Review, H2 2019
... family. It is a potent inhibitor of cell death. It inhibits activation of caspases. It regulate cell death ... preventing the release of the caspase activator (CYC1) from the ... molecules developed by companies in Phase III, Phase II and Preclinical stages ...

Apoptosis: Market Research Report
This report analyzes the worldwide markets for Apoptosis in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the ...

Mitogen Activated Protein Kinase Kinase Kinase 5 - Pipeline Review, H2 2019
Mitogen Activated Protein Kinase Kinase Kinase 5 - Pipeline Review, H2 2019 SUMMARY Mitogen Activated Protein Kinase Kinase Kinase 5 (Apoptosis Signal Regulating Kinase 1 or MAPK/ERK Kinase Kinase 5 or MAP3K5 or EC 2.7.11.25) - Mitogen-activated protein ...

Mitogen Activated Protein Kinase Kinase Kinase 5 - Pipeline Review, H1 2020
Mitogen Activated Protein Kinase Kinase Kinase 5 - Pipeline Review, H1 2020 SUMMARY Mitogen Activated Protein Kinase Kinase Kinase 5 (Apoptosis Signal Regulating Kinase 1 or MAPK/ERK Kinase Kinase 5 or MAP3K5 or EC 2.7.11.25) - Mitogen-activated protein ...








Copyright ©  chemBlink. 版权所有. 免责声明 | 网站简介 | 在线联系